Prenetics raises full-year revenue outlook to $220 million-$230 million
PRE•Revenue outlook raised after record quarter
Prenetics raised full-year total revenue guidance to $220 million-$230 million.
The company initiated 2027 IM8 revenue guidance of $400 million or more.
The outlook follows a sixth consecutive record quarter, with July the biggest month in company history.
Consolidated adjusted free cash flow turned positive for the first time, with expectations it remains positive.
